Bruker Corporation  

(Public, NASDAQ:BRKR)   Watch this stock  
Find more results for Anthony Emmerich
19.21
+0.34 (1.80%)
Nov 24 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 18.76 - 19.24
52 week 17.26 - 24.93
Open 18.91
Vol / Avg. 539,017.00/991,838.00
Mkt cap 3.18B
P/E 49.37
Div/yield     -
EPS 0.39
Shares 168.48M
Beta 1.24
Inst. own 67%
Feb 16, 2015
Q4 2014 Bruker Corp Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Dec 3, 2014
Bruker Corp at ISI MedTools & Outsourcing Investor Forum - 8:00AM EST - Add to calendar
Nov 12, 2014
Bruker Corp at Credit Suisse Healthcare Conference
Nov 6, 2014
Q3 2014 Bruker Corp Earnings Call
Nov 6, 2014
Q3 2014 Bruker Corporation Earnings Release
Sep 8, 2014
Bruker Corp at Morgan Stanley Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 1.50% 4.45%
Operating margin 1.17% 8.06%
EBITD margin - 12.61%
Return on average assets 1.29% 4.26%
Return on average equity 2.61% 10.32%
Employees 3,060 -
CDP Score - -

Address

40 MANNING RD
BILLERICA, MA 01821
United States - Map
+1-978-6633660 (Phone)
+1-978-6635585 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Bruker Corporation (Bruker) is a global manufacturer of scientific instruments that address the rapidly evolving needs of a diverse array of customers in life science, pharmaceutical, biotechnology, clinical and molecular diagnostics research, as well as in materials and chemical analysis in various industries and government applications. The Company�s technology platforms include magnetic resonance technologies, mass spectrometry technologies, X-ray technologies, spark-optical emission spectroscopy, atomic force microscopy, stylus and optical metrology technology and infrared and Raman molecular spectroscopy technologies. Its manufacture and distribute a broad range of field analytical systems for chemical, biological, radiological, nuclear and explosives, or CBRNE, detection. In April 2012, it acquired SkyScan N.V. In September 2013, the Company announced that it has acquired Prairie Technologies, Inc. In July 2014, the Company acquired Vutara Incorporated.

Officers and directors

Frank H. Laukien Ph.D. Chairman of the Board, President, Chief Executive Officer
Age: 54
Bio & Compensation  - Reuters
Charles F. Wagner Jr. Chief Financial Officer, Executive Vice President
Age: 46
Bio & Compensation  - Reuters
Thomas W. Bachmann President of Bruker BioSpin Group
Age: 60
Bio & Compensation  - Reuters
Bernd Gewiese Ph.D. Co-President of Bruker BioSpin Corporation
Age: 55
Bio & Compensation  - Reuters
Werner E. Maas Ph.D. Co-President of Bruker BioSpin Corporation
Age: 49
Bio & Compensation  - Reuters
Mark R. Munch Ph.D. President, Bruker Nano Surfaces Division and Bruker MAT Group
Age: 52
Bio & Compensation  - Reuters
Juergen Srega President of Bruker CALID Group
Age: 59
Bio & Compensation  - Reuters
Anthony L. Mattacchione Senior Vice President - Corporate Finance and Accounting
Age: 51
Bio & Compensation  - Reuters
Michael Gunnar Knell Vice President - Finance, Chief Accounting Officer
Age: 37
Bio & Compensation  - Reuters
William A. Linton Lead Independent Director
Age: 66
Bio & Compensation  - Reuters